FDA Recalls Losartan Lots, Another Blood Pressure Drug Contaminated With a Cancer Causing Impurity

The United States Food and Drug Administration (FDA) has issued more recalls for the blood pressure medication losartan. The latest recall notices were issued on Friday as two separate, voluntary recalls, both being issued in conjunction with Missouri-based Legacy Pharmaceuticals Packaging, LLC. No adverse effects related to these recalled hypertension drugs have been reported. Lists […]

A Third Type of Carcinogen Was Found in Blood Pressure Medication, FDA Says

The U.S. Food and Drug Administration has found a third type of cancer-causing impurity leading to the recall of blood pressure medications. Nearly 90 lots of Losartan potassium tablets made by Hetero Labs in India and distributed by Camber Pharmaceuticals were recalled Thursday due the discovery of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid […]

FDA Recalls More Blood Pressure Medication

The United States Food and Drug Administration (FDA) announced another blood pressure medication recall for one lot of losartan tablets, according to a safety announcement posted on the agency’s website. The latest voluntary blood pressure drug recall includes a lot of losartan potassium/hydrochlorothiazide combination tablets manufactured by Macleods Pharmaceuticals Limited. These blood pressure meds are […]